Curated Health Wellness News

NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.

Kairos Pharma Expands Pipeline with CL-741 Acquisition

June 4, 2026Kairos Pharma (KAPA) announces mid-year 2026 update, plans to acquire CL-741 from Celyn Therapeutics, and advances ENV-105 trials in prostate and lung cancer. Learn about the company's pipeline and non-dilutive funding.